Comparison of Maternal and Neonatal Outcome Following Cesarean Section at 38-40 Weeks

سال انتشار: 1399
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 309

فایل این مقاله در 5 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IRJN-11-2_009

تاریخ نمایه سازی: 24 تیر 1399

چکیده مقاله:

Background: The rate of Cesarean section is increasing which may be due to maternal and neonatal issues. Preterm Cesarean (at 38-39 weeks) has several morbidities and leads to maternal problems. The goal of this study was to compare neonatal and maternal complications following the performance of the Cesarean section after 38 weeks.Methods: This cross-sectional study evaluated 1010 subjects with term Cesarean section that referred to Yas hospital, in Tehran, Iran during 2015-7. The participants were divided into three groups based on the week of delivery. Afterward, they were studied for different neonatal and maternal complications.Results: According to the findings, the risk of adverse neonatal outcomes had a statistically negative relationship with the progress of gestational age. Moreover, the rate of hypoglycemia and hyperbilirubinemia and stillbirth was higher in neonates delivered before 38 weeks. Among the maternal complications, the rate of massive bleeding during cesarean section or in the postpartum period was significantly higher in deliveries before 39 weeks, whereas the rate of pelvic infection was higher in deliveries after 40 weeks.Conclusion: Based on the results of this study, the best time for the Cesarean section is the 39th week of pregnancy which led to the elimination of maternal and neonatal complications.

کلیدواژه ها:

Cesarean section ، Gestational Age ، maternal and neonatal complications

نویسندگان

Mahboobeh Shirazi

Maternal, Fetal, and Neonatal Research Center, Tehran University of Medical Sciences, Tehran, Iran

Marjan Ghaemi

Department of Obstetrics and Gynecology, Yas Hospital, Tehran University of Medical Sciences, Tehran, Iran

Shirin Niroomanesh

Maternal, Fetal, and Neonatal Research Center, Tehran University of Medical Sciences, Tehran, Iran

fatemeh Rahimi-Sharbaf

Maternal, Fetal, and Neonatal Research Center, Tehran University of Medical Sciences, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • World Health Organization, World Health Organization. Nutrition for Health. WHO ...
  • Spong CY, Mercer BM, D’Alton M, Kilpatrick S, Blackwell S, ...
  • Wen SW, Smith G, Yang Q, Walker M. Epidemiology of ...
  • Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, ...
  • Lindström K. Long-term consequences of preterm birth: swedish national cohort ...
  • Flood K, Malone FD. Prevention of preterm birth. Semin Fetal ...
  • Aarnoudse-Moens CS, Weisglas-Kuperus N, van Goudoever JB, Oosterlaan J. Meta-analysis ...
  • Ward RM, Beachy JC. Neonatal complications following preterm birth. BJOG. ...
  • Engle WA, Kominiarek MA. Late preterm infants, early term infants, ...
  • Bastek JA, Sammel MD, Paré E, Srinivas SK, Posencheg MA, ...
  • Raju TN, Higgins RD, Stark AR, Leveno KJ. Optimizing care ...
  • and Human Development. Pediatrics. 2006; 118(3): 1207-14. ...
  • Swamy GK, Ostbye T, Skjaerven R. Association of preterm birth ...
  • Bailit JL, Gregory KD, Reddy UM, Gonzalez-Quintero VH, Hibbard JU, ...
  • Houweling LM, Bezemer ID, Penning-van Beest FJ, Meijer WM, van ...
  • Tita AT, Landon MB, Spong CY, Lai Y, Leveno KJ, ...
  • Wilmink FA, Hukkelhoven CW, Lunshof S, Mol BW, van der ...
  • Signore C, Klebanoff M. Neonatal morbidity and mortality after elective ...
  • Murphy VE, Smith R, Giles WB, Clifton VL. Endocrine regulation ...
  • Laopaiboon M, Lumbiganon P, Intarut N, Mori R, Ganchimeg T, ...
  • Somboonviboon W, Kyokong O, Charuluxananan S, Narasethakamol A. Incidence and ...
  • Hansen AK, Wisborg K, Uldbjerg N, Henriksen TB. Risk of ...
  • Villar J, Valladares E, Wojdyla D, Zavaleta N, Carroli G, ...
  • نمایش کامل مراجع